Objective. Chronic periaortitis (CP) is a rare disease characterized by fibro-inflammatory tissue surrounding the abdominal aorta and the iliac arteries. Anecdotal reports have shown that CP may also involve other vascular districts, particularly the thoracic aorta. The aim of this study was to investigate the thoracic aorta and epiaortic artery involvement in CP.
Introduction
Chronic periaortitis (CP) is a rare disease characterized by fibro-inflammatory tissue spreading from the abdominal aorta and the iliac arteries into the surrounding retroperitoneum. CP includes non-aneurysmal [idiopathic retroperitoneal fibrosis (IRF)] and aneurysmal forms [inflammatory abdominal aortic aneurysms (IAAAs), perianeurysmal retroperitoneal fibrosis (PRF)] [13] . Histology reveals pronounced fibrosis and a chronic inflammatory infiltrate [4] , and in some cases IgG4 + plasma cell infiltration, which is why CP is included in the spectrum of IgG4-related disease (IgG4-RD), a newly recognized condition that often involves other sites (e.g. pancreas, salivary glands) [5] . CP was initially thought to result from a localized inflammatory response to aortic atherosclerotic plaque antigens [3] , but recent findings including the association with other autoimmune diseases and with HLA-DRB1*03 and the presence of systemic clinical manifestations [2, 6] suggest a systemic immune-mediated origin. This hypothesis is reinforced by descriptions of CP involving not only the abdominal aorta, but also other vascular areas (e.g. thoracic aorta) [7, 8] . We here explored the frequency and patterns of involvement of the thoracic aorta and epiaortic arteries in CP patients and investigated whether CP with thoracic vessel involvement represents a distinct disease form.
Patients and methods

Eligibility criteria, imaging and laboratory examinations
Between 1999 and 2012, 153 consecutive CP patients were seen at our centre. CP was diagnosed by abdominal CT or MRI, following commonly accepted criteria [9] . When available, whole-body [ [10] . IgG4 levels (normal, 8140 mg/dl) were assessed in a fraction of patients, as this test became available at our centre in 2007. We excluded secondary causes of retroperitoneal fibrosis (e.g. drugs, malignancies, ErdheimChester disease) [11] , genetically determined diseases causing aortic aneurysms (e.g. Marfan's, Turner's and EhlersDanlos syndromes), infectious aortitis, GCA and Takayasu's arteritis (TA) [12] .
CP patients were eligible for this study if they had appropriate imaging studies examining the inflammatory involvement of the thoracic aorta and its major branches, which included contrast-enhanced chest CT or MRI and whole-body 18 F-FDG PET-CT. CT was performed with a multidetector scanner (1 mm sections) before and after contrast medium injection in arterial and venous phases. Chest MRI studies were performed with a 1.5T MRI system using a phased array torso coil. We examined axial T1-and T2-weighted, fat-and non-fat-suppressed imaging sequences. A T1-weighted three-dimensional gradient echo sequence in the axial plane was performed with fat suppression 35 and 90 s from the beginning of contrast injection. The radiologist evaluated the presence of the perivascular tissue, its thickness, MRI/CT features and contrast enhancement using a region of interest. The aortic diameter was measured (not including the vessel wall) using multiplanar reformatted imaging. On PET, vascular FDG uptake was graded using a 4-point scale: 0, no uptake; 1, low-grade uptake (lower than liver uptake); 2, intermediate-grade uptake (similar to liver uptake); and 3, high-grade uptake (between liver and cerebral uptake or similar to the uptake in the cerebral cortex). Scores of 01 were considered negative, while scores of 23 were considered positive. The study was approved by the ethics committee of the University Hospital of Parma (Comitato Etico per Parma). All participants signed an informed consent form. Privacy was preserved through the adoption of alphanumeric codes as identifiers.
Histological analysis of CP biopsies
Retroperitoneal or abdominal aortic biopsies and, when available, thoracic aorta or carotid artery biopsies (in patients undergoing aortic aneurysmectomy or carotid endarterectomy) were analysed for diagnostic purposes as previously described [4] . The slides were stained using routine techniques [4] . 
Results
Thoracic vessel disease patterns in CP
Of the 153 patients screened, 77 were eligible for this study; 69 had IRF ( Fig. 1A and B) and 8 had IAAA/PRF. Twenty-eight cases (36%) showed thoracic aorta and/or epiaortic artery involvement; this was diagnosed in 9/28 cases by contrast chest CT, in 4/28 by contrast MRI (2 completed the examination with contrast-enhanced magnetic resonance angiography) and in 15/28 by 18 F-FDG PET-CT. In these 28 cases, the following patterns of thoracic vessel involvement were identified (Fig. 1) . Thoracic periaortitis (15/28 patients, 54%) had the hallmark of a perivascular soft tissue mass surrounding a thoracic aorta of normal calibre. The tissue was usually homogeneous with no infiltrative features. On non-enhanced CT, its density was similar to that of the thoracic wall muscles. The tissue had low signal intensity on T1-weighted MRI, whereas on T2-weighted scans the signal intensity was usually high. The perivascular tissue enhancement was variable on CT/ MRI, probably reflecting disease activity: it was early and avid during active phases and non-significant during inactive phases. On PET, the median 18 F-FDG uptake grade was 3+ (IQR 34+) around the abdominal aorta and 3+ (IQR 34+) around the thoracic aorta. In 13/15 cases with thoracic periaortitis the perivascular tissue surrounded the ascending aorta, the aortic arch and the upper descending aorta ( 2 cases it involved the lower descending aorta. Seven of 15 patients also showed perivascular involvement of the origin of the epiaortic arteries (common carotid in 5, left subclavian in 1 and brachiocephalic in 1) (Fig. 1F) . In thoracic aortic aneurysm with periaortitis [6/28 cases (21%)], the characteristics of the perivascular tissue were similar to those described above, but the thoracic aorta showed aneurysmal dilatation (>50% of the expected normal diameter). Epiaortic vessel involvement was found in two cases (common carotid arteries in both and left subclavian in one). In thoracic aortic aneurysm without periaortitis [7/28 patients (25%)], the aneurysm involved the ascending aorta in 5 cases, the aortic arch and descending aorta in 1, and the ascending aorta, the aortic arch and the descending aorta in 1. We included thoracic aortic aneurysm without periaortitis as a diseaserelated manifestation because it is a potential complication of large vessel vasculitides. Thoracic vessel disease was symptomatic in only four patients (14%); in these cases thoracic periaortitis was always associated with epiaortic involvement. Two patients had hoarseness secondary to recurrent laryngeal nerve paralysis. Unilateral deficit in arm strength, asymmetrical pulses/blood pressure values were observed in two patients and arm claudication, upper limb paresthesias and dry cough were found in three patients. Four patients underwent thoracic aneurysm repair (two surgical, two endovascular) and two carotid endoarterectomy.
CP histology
Retroperitoneal biopsies were available in 46% of patients with and 47% of patients without thoracic involvement, whereas thoracic CP biopsies were available in three patients (two after carotid endarterectomy and one after surgical repair of thoracic aortic aneurysm). Histological examination of abdominal biopsies showed a typical CP pattern and no differences in histological features were found in patients with vs without thoracic involvement. Histology of the thoracic tissue was strikingly similar to that found in abdominal CP [4] . The pathological lesions in thoracic CP involved the adventitia and the periadventitial tissue and consisted of a fibrous component and a chronic inflammatory infiltrate (supplementary Fig.  S1 , available at Rheumatology Online), as described in abdominal CP [2, 4] . The inflammatory infiltrate displayed perivascular and diffuse patterns and consisted of lymphocytes, histiocytes, plasma cells and eosinophils. The follicular aggregates, often with germinal centres, were rich in lymphocytes, which clustered around adventitial vasa vasorum ( Supplementary Fig. S1 , available at Rheumatology Online). Immunohistochemistry revealed in two of these three cases (one with thoracic periaortitis and epiaortic artery involvement, the other with thoracic periaortitis plus aneurysm) an IgG4 + :CD138 + plasma cell ratio >40% (the cut-off used to define CP as IgG4 related) [13] .
Demographic, laboratory and clinical features in patients with and without thoracic disease
Patients with thoracic involvement had a significantly higher female prevalence (P = 0.01), a greater age at disease onset (P = 0.001), a higher prevalence of systemic symptoms (e.g. fatigue, anorexia, weight loss) (P = 0.02) and back or abdominal pain (P = 0.02) ( Table 1) . Patients with thoracic disease also tended to have higher ESR and CRP level than patients without thoracic disease, although the differences were not statistically significant. Similar proportions of patients in the two groups had other autoimmune diseases, the most common of which were autoimmune thyroiditis and psoriasis. IgG4 measurement was available in 45/77 patients (58%); serum IgG4 levels (data not shown) and the percentage of patients with high IgG4 did not differ in the two groups (Table 1) , so IgG4 did not characterize a CP subset with more frequent extraretroperitoneal lesions, in contrast to previously reported data [13, 14] .
Discussion
CP is usually thought to be confined to the abdominal aorta and the iliac arteries and its pathogenesis is considered secondary to a localized inflammatory reaction to atherosclerotic plaque antigens [3, 15] . Our study challenges this view and shows that in one-third of patients it also involves the thoracic aorta and the epiaortic arteries. This may suggest that in such cases, CP actually represents a primary, diffuse inflammatory disease of the aorta and its major branches. Anecdotal reports have described in CP the occurrence of periarteritis involving large arteries such as the coronary [16, 17] , renal, mesenteric and coeliac axis [18] . Interestingly, autopsy studies in CP showed adventitial inflammation in aortic sections (mainly at the thoracic aorta level) lacking periaortic fibrosis, suggesting the presence of widespread aortic disease and implying a transition from adventitial inflammation to fibrosis [7] . Molecular analysis of CP biopsies revealed gene transcripts (IFN-g, IL-2 and IL-4), indicating lymphocyte activation within the aorta wall [19] . Finally, the pattern of vascular inflammation in CP is also consistent with an inflammatory vascular disease: as in GCA and TA, inflammation in CP predominates in the adventitia. This was seen on abdominal aortic biopsies [3, 10] and also in the thoracic aortic biopsies examined here, where the lymphomonocytic infiltrate typically involves the adventitia and the mediaadventitia border. Adventitial vasa vasorum, a possible port of entry for disease-triggering pathogens in GCA [20] , are often inflamed in CP; in addition, the observed adventitial germinal centres are the expression of ectopic lymphoneogenesis, a feature of many autoimmune diseases. These findings suggest that CP may arise as a primary large artery inflammatory disease, which in some patients is localized to the abdominal aorta and iliac arteries and in others extends to other vascular segments.
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Large vessel involvement in chronic periaortitis thoracic aortic aneurysms without periaortitis. All these patterns can be seen in other large vessel diseases, primarily GCA and TA, which often affect not only the epiaortic tree, but also the thoracic and abdominal aorta. GCA and TA usually lack the thick periaortic cuff seen in CP, and GCA features cranial symptoms (e.g. scalp tenderness, visual abnormalities) that are almost absent in CP. However, some GCA and TA patients present with isolated nonspecific manifestations, such as systemic symptoms, that make the differential diagnosis more challenging. One distinguishing feature between CP and GCA/TA is ureteral involvement, which is only found in CP [9, 11] .
When managing CP patients with thoracic aorta involvement it is mandatory to exclude two other diseases presenting with similar features: ErdheimChester disease, a non-Langerhans cell histiocytosis, that presents with symmetrical long bone involvement and often peri-renal fibrosis, and IgG4-RD. Recent reports have shown that CP belongs to the spectrum of IgG4-RD, as both IRF and IAAA are characterized, in 4050% of cases, by numerous IgG4 + -infiltrating plasma cells [5, 13] . Two of the three thoracic aorta/carotid biopsies available in our patients had significant IgG4 + plasma cell infiltration, suggesting an overlap between CP and IgG4-RD, but these patients lacked involvement of other sites by IgG4-RD. The comparison of demographic and clinical characteristics of patients with and without thoracic involvement revealed that these subgroups were different. Patients with thoracic disease were more frequently female and Established atherosclerotic disease comprises ischaemic heart disease, cerebrovascular disease and peripheral arterial disease; these were recorded during the entire follow-up. CP: chronic periaortitis; CV: cardiovascular; Hb: haemoglobin; IQR: interquartile range; WBC: white blood cell.
older-characteristics reminiscent of a GCA phenotypeand the frequency of disease-related symptoms was also higher in this group.
In conclusion, in about one-third of patients CP is not limited to the abdominal aorta, but also involves the thoracic aorta and the epiaortic arteries. Active adventitial inflammation is seen in both thoracic and abdominal aorta biopsies, a pattern that suggests that CP may be a primary large vessel inflammatory disease.
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